The federal government provides funding for human embryonic stem cell research only to scientists working on approved lines of pre-existing stem cells. Privately funded researchers at many businesses and academic institutions, however, are pursuing studies on stem cells derived from donated embryos and not included in the approved lines. Several states also are considering funding a wider array of stem cell research. In the absence of federal regulations to govern broader stem cell research, a committee of the National Academies' National Research Council and Institute of Medicine is developing voluntary guidelines to encourage responsible stem cell research. At this two-day workshop hosted by the committee, scientists, ethicists, and policy-makers will discuss the appropriate use and handling of stem cells derived from frozen embryos originally intended for in vitro fertilization procedures, as well as those derived from a process scientists call somatic cell nuclear transfer that is often referred to as therapeutic cloning.
DETAILS: Tuesday, Oct. 12, and Wednesday, Oct. 13, from 8:30 a.m. to 5 p.m. each day. The first day's meeting will take place in the Auditorium of the National Academies building, 2100 C St., N.W., Washington, D.C. The second day's sessions will be held in the Lecture Room of the same building.
REPORTERS: Seating is limited, and reporters should register in advance with the Office of News and Public Information; tel. 202 334-2138 or e-mail firstname.lastname@example.org. Reporters who cannot attend may listen to a live audio webcast at http://national-academies.org. (The webcast requires RealPlayer software, available free at http://www.real.com/player. For more information on setup and hardware requirements, see the Real.com site.)
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.
It's not having been in the dark house, but having left it, that counts.
-- Theodore Roosevelt